查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1591791

幽门螺旋桿菌非侵入性检测市场：按测试类型、测试方法、最终用户划分 - 全球预测 2025-2030

Helicobacter Pylori Non-invasive Testing Market by Test Type (Breath Test, Serology Test, Stool Antigen Test), Test Method (Laboratory-Based Tests, Point-of-care Tests, Rapid Test Kit), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

幽门螺旋桿菌非侵入性检测市场2023年估值为10.6亿美元，预计2024年将达到11.2亿美元，复合年增长率为5.70%，到2030年复合年增长率为15亿美元。 。

幽门螺旋桿菌（H. pylori）非侵入性检测是胃肠道诊断的重要组成部分，无需内视镜操作即可检测出幽门螺旋桿菌病菌感染。这些测试包括尿素呼气测试、粪便抗原测试和血液抗体测试，每种测试在准确性、成本和患者便利性方面都具有独特的优势。对非侵入性检测的需求源于这样一个事实：幽门螺旋桿菌与多种胃肠道疾病有关，包括消化性溃疡和胃癌，早期检测对于有效的治疗和管理至关重要。这些测试的主要最终用户包括医院、诊断实验室和诊所，随着对家庭诊断解决方案的需求不断增加，扩大了其在家庭医疗保健环境中的使用。

主要市场统计
基准年[2023] 10.6亿美元
预测年份 [2024] 11.2亿美元
预测年份 [2030] 15.7亿美元
复合年增长率（%） 5.70%

市场成长要素包括胃肠道疾病盛行率的上升、人们对幽门螺旋桿菌对健康影响的认识不断增强以及向非侵入性诊断方法的转变。技术进步，例如测试灵敏度和特异性的提高，正在扩大市场机会。新兴市场存在重大机会，医疗保健支出的增加和基础设施的改善为市场扩张提供了肥沃的土壤。抓住这些机会的建议包括专注于具有成本效益的便携式测试创新以及扩大服务欠缺地区的分布。

然而，市场成长面临的挑战包括先进诊断设施的使用有限以及资源匮乏地区的严格监管标准。此外，侵入性替代检测方法的存在也是竞争的来源。为了克服这些挑战，公司可以投资于提高测试准确性和易用性的技术，并倡导医疗保健专业人员和患者等提高对非侵入性选择的认识和理解。创新应专注于开发与数位健康平台整合并实现无缝健康监测和资料利用的测试。总体而言，市场是动态的，如果公司有效利用技术进步并制定解决可访问性问题的策略，市场就会显着成长。

市场动态：快速发展的幽门螺旋桿菌非侵入性检测市场的关键市场洞察

供需的动态交互作用正在改变幽门螺旋桿菌非侵入性检测市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 幽门螺旋桿菌病菌感染盛行率增加
    • 胃溃疡盛行率上升
    • 政府提高对感染的认识以进行正确诊断
  • 市场限制因素
    • 即使在高流行地区诊断率也很低
  • 市场机会
    • 提供新型和先进的非侵入性测试，例如即时PCR和化学冷光免疫检测(CLIA)
    • 对现场检测设备的需求不断增长
  • 市场挑战
    • 无症状性感染疾病，监管标准严格

波特五力：驾驭幽门螺旋桿菌无创检测市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解幽门螺旋桿菌非侵入性检测市场的外部影响

外部宏观环境因素在塑造幽门螺旋桿菌非侵入性检测市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解幽门螺旋桿菌非侵入性检测市场的竞争格局

对幽门螺旋桿菌非侵入性检测市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵幽门螺旋桿菌非侵入性检测市场供应商绩效评估

FPNV定位矩阵是评估幽门螺旋桿菌非侵入性检测市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製幽门螺旋桿菌非侵入性检测市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对幽门螺旋桿菌非侵入性检测市场进行策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 幽门螺旋桿菌病菌感染的传播
      • 胃溃疡的发生率增加
      • 政府意识提升以进行正确诊断
    • 抑制因素
      • 即使在患病率高的地区，诊断率也很低。
    • 机会
      • 提供新的先进非侵入性测试，例如即时PCR和化学冷光免疫检测(CLIA)
      • 就地检验设备的需求增加
    • 任务
      • 无症状感染者和严格的监管标准
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依检测类型分類的幽门螺旋桿菌非侵入性检测市场

  • 呼吸检测
  • 血清检测
  • 粪便抗原检测

第七章 幽门螺旋桿菌非侵入性检测市场（依检测方法）

  • 基于实验室的测试
  • 就地检验
  • 快速检测套组

第八章幽门螺旋桿菌非侵入性检测市场：依最终使用者分类

  • 诊所
  • 医院

第九章 美洲幽门螺旋桿菌非侵入性检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章 亚太地区幽门螺旋桿菌非侵入性检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲幽门螺旋桿菌非侵入性检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Alere Inc.
  • Bio-Rad Laboratories, Inc.
  • Biomerica, Inc.
  • Certest Biotec SL
  • CorisBioconcept SPRL
  • DiaSorin SPA
  • Exalenz Bioscience Ltd
  • Medline Industries, Inc.
  • Meridian Bioscience Inc.
  • Quidel Corporation
  • Sekisui Diagnostics, LLC
  • Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
  • Siemens Healthcare Private Limited
  • Thermo Fisher Scientific, Inc
Product Code: MRR-437E9896A586

The Helicobacter Pylori Non-invasive Testing Market was valued at USD 1.06 billion in 2023, expected to reach USD 1.12 billion in 2024, and is projected to grow at a CAGR of 5.70%, to USD 1.57 billion by 2030.

Helicobacter pylori (H. pylori) non-invasive testing is a crucial component of gastrointestinal diagnostics, allowing for the detection of H. pylori infections without the need for endoscopic procedures. This testing method encompasses urea breath tests, stool antigen tests, and blood antibody tests, with each offering specific advantages in terms of accuracy, cost, and patient convenience. The necessity of non-invasive testing arises from H. pylori's association with various gastrointestinal disorders, including peptic ulcers and gastric cancer, making early detection critical for effective treatment and management. The primary end-users of these tests include hospitals, diagnostic laboratories, and clinics, with a growing application in home healthcare settings, driven by increasing demand for at-home diagnostic solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 1.06 billion
Estimated Year [2024] USD 1.12 billion
Forecast Year [2030] USD 1.57 billion
CAGR (%) 5.70%

Growth factors in the market include rising prevalence of gastrointestinal diseases, increasing awareness about H. pylori's health implications, and the shift towards non-invasive diagnostic methods. Advances in technology, such as improved sensitivity and specificity of tests, expand market opportunities. A significant opportunity lies in emerging markets where increasing healthcare expenditure and improving infrastructure provide fertile ground for market expansion. Recommendations for capturing these opportunities include focusing on cost-effective and portable testing innovations and expanding distribution in underserved regions.

However, market growth is challenged by factors such as limited accessibility to advanced diagnostic facilities in low-resource areas and strict regulatory norms. Additionally, the presence of alternative, invasive testing methods can pose competition. To overcome these challenges, businesses are advised to invest in technology that enhances test accuracy and ease of use, and to advocate for increased awareness and understanding of non-invasive options among healthcare professionals and patients alike. Innovation should focus on developing tests that integrate with digital health platforms, enabling seamless health monitoring and data use. Overall, the market is dynamic, with strong growth potential, provided companies effectively harness technological advancements and strategize to address accessibility issues.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Helicobacter Pylori Non-invasive Testing Market

The Helicobacter Pylori Non-invasive Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of Helicobacter pylori bacterial infection
    • Rising prevalence of gastric ulcer
    • Increasing awareness regarding infection by the government for proper diagnosis
  • Market Restraints
    • Low diagnosis rates even in high prevalence geographies
  • Market Opportunities
    • Availability of new and advanced non-invasive tests such as real-time PCR and Chemiluminescence Immunoassay (CLIA)
    • Growing demand for point of care testing devices
  • Market Challenges
    • Asymptomatic nature of the infection, and stringent regulatory norms

Porter's Five Forces: A Strategic Tool for Navigating the Helicobacter Pylori Non-invasive Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Helicobacter Pylori Non-invasive Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Helicobacter Pylori Non-invasive Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Helicobacter Pylori Non-invasive Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Helicobacter Pylori Non-invasive Testing Market

A detailed market share analysis in the Helicobacter Pylori Non-invasive Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Helicobacter Pylori Non-invasive Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Helicobacter Pylori Non-invasive Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Helicobacter Pylori Non-invasive Testing Market

A strategic analysis of the Helicobacter Pylori Non-invasive Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Helicobacter Pylori Non-invasive Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alere Inc., Bio-Rad Laboratories, Inc., Biomerica, Inc., Certest Biotec SL, CorisBioconcept SPRL, DiaSorin S.P.A., Exalenz Bioscience Ltd, Medline Industries, Inc., Meridian Bioscience Inc., Quidel Corporation, Sekisui Diagnostics, LLC, Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd., Siemens Healthcare Private Limited, and Thermo Fisher Scientific, Inc.

Market Segmentation & Coverage

This research report categorizes the Helicobacter Pylori Non-invasive Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Test Type, market is studied across Breath Test, Serology Test, and Stool Antigen Test.
  • Based on Test Method, market is studied across Laboratory-Based Tests, Point-of-care Tests, and Rapid Test Kit.
  • Based on End-User, market is studied across Clinics and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of Helicobacter pylori bacterial infection
      • 5.1.1.2. Rising prevalence of gastric ulcer
      • 5.1.1.3. Increasing awareness regarding infection by the government for proper diagnosis
    • 5.1.2. Restraints
      • 5.1.2.1. Low diagnosis rates even in high prevalence geographies
    • 5.1.3. Opportunities
      • 5.1.3.1. Availability of new and advanced non-invasive tests such as real-time PCR and Chemiluminescence Immunoassay (CLIA)
      • 5.1.3.2. Growing demand for point of care testing devices
    • 5.1.4. Challenges
      • 5.1.4.1. Asymptomatic nature of the infection, and stringent regulatory norms
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Helicobacter Pylori Non-invasive Testing Market, by Test Type

  • 6.1. Introduction
  • 6.2. Breath Test
  • 6.3. Serology Test
  • 6.4. Stool Antigen Test

7. Helicobacter Pylori Non-invasive Testing Market, by Test Method

  • 7.1. Introduction
  • 7.2. Laboratory-Based Tests
  • 7.3. Point-of-care Tests
  • 7.4. Rapid Test Kit

8. Helicobacter Pylori Non-invasive Testing Market, by End-User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Hospitals

9. Americas Helicobacter Pylori Non-invasive Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Helicobacter Pylori Non-invasive Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Helicobacter Pylori Non-invasive Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Alere Inc.
  • 3. Bio-Rad Laboratories, Inc.
  • 4. Biomerica, Inc.
  • 5. Certest Biotec SL
  • 6. CorisBioconcept SPRL
  • 7. DiaSorin S.P.A.
  • 8. Exalenz Bioscience Ltd
  • 9. Medline Industries, Inc.
  • 10. Meridian Bioscience Inc.
  • 11. Quidel Corporation
  • 12. Sekisui Diagnostics, LLC
  • 13. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
  • 14. Siemens Healthcare Private Limited
  • 15. Thermo Fisher Scientific, Inc

LIST OF FIGURES

  • FIGURE 1. HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY BREATH TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY LABORATORY-BASED TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY POINT-OF-CARE TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY RAPID TEST KIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET, FPNV POSITIONING MATRIX, 2023